Bastide Le Confort Médical

Capital/Financing Update • Nov 29, 2021

Press release

Groupe Bastide optimizes the refinancing of its debt and displays CSR criteria that can improve its interest rate

Caissargues, November 29, 2021 – 05h45 pm CET – Bastide Le Confort Médical (Euronext Paris Compartment B: BLC, FR0000035370), a specialist in the supply of medical devices and home care services, announces that it has carried out a refinancing operation through the early renewal of its syndicated loan. The maturity of the tranches of the credit agreement is now fixed at 3 years with two additional potential years at the lenders' discretion. The amount of the first amortizable tranche is set at €25 million and the amount of the second tranche repayable at maturity is €170 million, compared to €50 million previously. At the same time, the Group reduced the size of its Revolving Credit Facility from €140 million to €60 million, with the possibility of mobilizing an additional €20 million, if necessary, through an accordion clause¹ .

The margin applied to these credit facilities will depend on the Group's leverage ratio² but also on compliance with CSR indicators defined on the basis of the pillars of Groupe Bastide's ESG strategy:

ESG pillar	Indicator	Target
Preserving our environment	Carbon footprint of the vehicle fleet	Reduction of 4.2% per year in line with the 1.5°C trajectory by 2050
Preserving our environment - Local impact	Reuse of medical devices in second life	20% increase over the period
Human resources/patient satisfaction	Employee training in business skills	20% increase over the period

The indexation mechanism put in place will allow the margin on its loan rate to be adjusted upwards or downwards depending on whether these objectives are met.

Groupe Bastide was advised in this transaction by ODDO-BHF which mobilized Société Générale as Credit Coordinator and MLA Bookrunner, NATIXIS as CSR Coordinator, Credit Agent and MLA Bookrunner, BNP and CACIB as MLA Bookrunners.

The optimization of these financing arrangements, coupled with two Euro PP bond issues of EUR 25 million each maturing in 2023 and 2024 respectively, give the Group ample financial leeway to pursue its development over the coming years, whether for organic growth or for external growth operations.

¹ An Accordion Clause is a special provision in a credit agreement that allows a company to access additional funds if needed

² Designated by the consolidated net financial debt at the date of calculation of the ratio / Consolidated EBITDA of the last 12 months

About Groupe Bastide Le Confort Médical

Created in 1977 by Guy Bastide, the BASTIDE Group is one of the main European providers of services (rental and sale) of Medical Devices. Present in 5 countries, BASTIDE is developing a permanent quality approach and is committed to providing medical devices and associated services that best meet the needs of patients in key health areas: diabetes, nutrition, perfusion, respiratory, stomatherapy and urology. BASTIDE is listed on Euronext Paris (ISIN: FR0000035370, Reuters BATD.PA, - Bloomberg BLC: FP).

Groupe Bastide	NewCap	NewCap
Vincent Bastide Olivier Jourdanney	Investor Relations	Press Relations
	Emmanuel Huynh / Théo Martin	Nicolas Merigeau
T. +33 (0)4 66 38 68 08	T. +33 (0)1 44 71 20 42	T. +33 (0)1 44 71 94 98
	bastide@newcap.eu	bastide@newcap.eu